France
Sanofi’s clinical trial of haemophilia A therapy in children meets endpoint
In the XTEND-Kids study, patients were given ALTUVIIIO prophylaxis (50 IU/kg) once-a-week for 52 weeks.
Ipsen reports positive data from pancreatic ductal adenocarcinoma trial
LinKinVax partners with Gustave Roussy for HPV vaccine candidate trial
Sanofi enlists Thread as decentralised clinical trial provider in new deal
Abionyx Pharma’s Phase IIa trial of CER-001 for AKI meets primary objective
Sensorion reports first patient enrolment in Phase IIa ototoxicity trial
French agency approves Affimed’s CTA for AML therapy trial
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
